Company: NUTR
Filing Date: 2025-03-25
Form Type: CORRESP
Source: 0001641172-25-000449
Chunk: 22

Company: NUSATRIP Inc
Filing Date: 2025-03-25
Form: CORRESP
Chunk 22
---
 Of the “Other Stockholders,” the holders of Common Stock to be issued upon the conversion
of the Convertible Notes would own an aggregate of 6.05.9%, and the holders of Common Stock offered in this Offering
would own an aggregate of 15.216.6%, of the outstanding Common Stock.

The subsidiaries shown in the foregoing chart are
currently owned by the Company, and the ownership of each such subsidiary shall not change upon or as a result of the consummation of
this offering.

As of the consummation of this offering, directors
of the Company, Vincent Puccio and Michael Freed will also will be director of Society Pass. These overlapping relationships could present
potential conflicts of interest. For more details, refer to “Risk Factors - We may have conflicts of interest with our Controlling
Stockholder and, because of our Controlling Stockholder’s controlling ownership interest in our Company, we may not be able to resolve
such conflicts on terms favorable to us.”

As of the date of this prospectus, the Company and
Society Pass are not parties to any support agreement, tax sharing arrangement, registration rights agreement or other written agreement.
As of the consummation of this offering, the Company and Society Pass will not be parties to any support agreement, tax sharing arrangement,
registration rights agreement or other written agreement.

| 8 |

Impact of the COVID-19 Pandemic and other Global Events

The full impact of the COVID-19 pandemic on our business,
financial condition and results of operations remains unpredictable due to the evolving nature of the COVID-19 pandemic and the extent
of its impact across industries and geographies and numerous other uncertainties. For example, we cannot predict the duration and spread
of the outbreak of new variants of the virus, additional actions that may be taken by governmental entities, or the impact the pandemic
may have on the ability of us, our customers, our suppliers, our manufacturers, and our other business partners to conduct business. To
date, COVID-19 has led to the implementation of various responses, including government-imposed quarantines, business closures, travel
restrictions, and other public health safety measures. The extent to which the COVID-19 pandemic impacts our business will depend on future
developments, which are highly uncertain and cannot be predicted at this time,.

The spread of COVID-19 caused us to modify our business
practices, including employee travel, employee work locations in certain cases, and cancellation of physical participation in certain
meet